Cargando…
Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol
BACKGROUND: Treatment of depression, the most prevalent and costly mental disorder, needs to be improved. Non-concordance with clinical guidelines and non-adherence can limit the efficacy of pharmacological treatment of depression. Through pharmaceutical care, pharmacists can improve patients'...
Autores principales: | Rubio-Valera, Maria, Serrano-Blanco, Antoni, Travé, Pere, Peñarrubia-María, M Teresa, Ruiz, Mar, Pujol, Marian March |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731750/ https://www.ncbi.nlm.nih.gov/pubmed/19656386 http://dx.doi.org/10.1186/1471-2458-9-284 |
Ejemplares similares
-
Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
por: Rubio-Valera, Maria, et al.
Publicado: (2013) -
Correction: Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
por: Rubio-Valera, Maria, et al.
Publicado: (2016) -
Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)
por: Rubio-Valera, Maria, et al.
Publicado: (2015) -
Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study)
por: Sánchez-Viñas, Alba, et al.
Publicado: (2022) -
Impacto de una intervención farmacéutica en la prevención de recaídas en depresión en atención primaria()
por: Rubio-Valera, María, et al.
Publicado: (2016)